Health ❯ Patient Care

Chronic Illness Management

Quality of Life Treatment Options ME/CFS Treatment Pain Management Parkinson's Disease Diabetes Management Support for Families Healthcare Efficiency Kidney Health Innovative Therapies Celiac Disease Celiac Disease Management Huntington's Disease Care Healthcare Models Therapeutic Approaches Treatment-Resistant Epilepsy Exercise Benefits Neurodegenerative Diseases Fibromyalgia Myasthenia Gravis Lifestyle Adjustments Independence in Illness Neurodegenerative Disorders Cystic Fibrosis Personalized Medicine Huntington's Disease Healthcare Challenges Patient Experiences Treatment Innovations Support Services ALS Patient Outcomes Supportive Care Cystic Fibrosis Treatment Diabetes Treatment Dietary Treatment Lupus Nephritis Treatment SMA Treatment Options Support Systems Rheumatoid Arthritis Communication Disorders Impact of IPF Innovative Treatments Support for Alzheimer's Patients Idiopathic Pulmonary Fibrosis Multiple Sclerosis Elderly Care Heart Disease Treatment Chronic Venous Insufficiency

Decoy Molecule Blocks Alpha‑Synuclein–ClpP Link, Reversing Mitochondrial Defects in Parkinson’s Models

Preclinical data point to a harmful protein interaction with a candidate that restores cellular energy systems.

Monthly Fasting-Mimicking Diet Shows Benefit in Mild Crohn’s, Randomized Trial Finds

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

FDA Approves Novartis’ Itvisma for SMA Patients Ages 2 and Up

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

Study Reports Blood Test That Detects ME/CFS With 96% Accuracy

Gene Therapy Slows Huntington’s Progression by 75% in Early Trial, uniQure Says

Biogen to Buy Alcyone for $85 Million, Gaining Rights to ThecaFlex DRx

2025 Lasker-DeBakey Award Honors Scientists Behind Trikafta’s Cystic Fibrosis Breakthrough

Soft Wireless Implant Shows Precise Drug Delivery to Deep Brain Regions

Subcutaneous EEG Implant Outperforms Self-Reporting in Long-Term Seizure Monitoring

Adaptive Cycling Alters Brain Activity in Parkinson’s Patients, Study Finds

Ambroxol Demonstrates Safety and Neuroprotection Signals in Parkinson’s Dementia Trial